These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 17273128)
1. Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Heurgué A; Vitry F; Diebold MD; Yaziji N; Bernard-Chabert B; Pennaforte JL; Picot R; Louvet H; Frémond L; Geoffroy P; Schmit JL; Cadiot G; Thiéfin G Gastroenterol Clin Biol; 2007 Jan; 31(1):17-25. PubMed ID: 17273128 [TBL] [Abstract][Full Text] [Related]
2. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990 [TBL] [Abstract][Full Text] [Related]
3. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study. Fan X; Zhu Y; Men R; Wen M; Shen Y; Lu C; Yang L Can J Gastroenterol Hepatol; 2018; 2018():1965492. PubMed ID: 30155449 [TBL] [Abstract][Full Text] [Related]
5. Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features. Wen M; Men R; Fan X; Shen Y; Ni P; Hu Z; Yang L Dig Dis; 2021; 39(4):366-374. PubMed ID: 33238269 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Ozaslan E; Efe C; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Muratori L; Ustündag Y; Bresson-Hadni S; Thiéfin G; Schiano TD; Wahlin S; Muratori P Clin Gastroenterol Hepatol; 2014 May; 12(5):863-9. PubMed ID: 24076417 [TBL] [Abstract][Full Text] [Related]
8. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416 [TBL] [Abstract][Full Text] [Related]
9. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Chazouillères O; Wendum D; Serfaty L; Rosmorduc O; Poupon R J Hepatol; 2006 Feb; 44(2):400-6. PubMed ID: 16356577 [TBL] [Abstract][Full Text] [Related]
10. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953 [TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes. Park Y; Cho Y; Cho EJ; Kim YJ Clin Mol Hepatol; 2015 Jun; 21(2):150-7. PubMed ID: 26157752 [TBL] [Abstract][Full Text] [Related]
12. Development of autoimmune hepatitis in primary biliary cirrhosis. Gossard AA; Lindor KD Liver Int; 2007 Oct; 27(8):1086-90. PubMed ID: 17845536 [TBL] [Abstract][Full Text] [Related]
13. Overlap syndromes among autoimmune liver diseases. Rust C; Beuers U World J Gastroenterol; 2008 Jun; 14(21):3368-73. PubMed ID: 18528934 [TBL] [Abstract][Full Text] [Related]
14. [Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A Ann Med Interne (Paris); 2003 Feb; 154(1):7-11. PubMed ID: 12746654 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center. Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070 [TBL] [Abstract][Full Text] [Related]